Competition Law and Policy in the Japanese Pharmaceutical Sector

This book offers an in-depth analysis of competition law and policy within Japan's pharmaceutical sector, addressing key regulations and industry challenges.

This comprehensive volume is the first to focus on competition law and policy specifically within the Japanese pharmaceutical sector. Competition Law and Policy in the Japanese Pharmaceutical Sector features contributions from leading academics who explore the industry through various lenses, including economics, competition law, pharmaceutical regulations, and intellectual property law. Each chapter delves into the unique aspects of Japan's healthcare system and how these influence competition policies in the pharmaceutical market.

The book begins with an overview of drug regulations and trade practices that are distinctive to Japan, highlighting the impact of the Japanese Antimonopoly Act and relevant case studies. It addresses contemporary issues in competition law as they pertain to the pharmaceutical industry, including the intricate relationship between innovation, intellectual property rights, and economic analysis. The comparative studies presented in the text offer valuable insights into how Japan's regulations stack up against those in the European Union and the United States.

As one of the largest pharmaceutical markets globally, Japan's regulatory landscape is critical for students, academics, industry professionals, and policymakers alike. Competition Law and Policy in the Japanese Pharmaceutical Sector serves as a vital resource for anyone interested in understanding the complexities of pharmaceutical regulations in Japan, from foundational concepts to advanced discussions on pressing policy challenges. Chapter 11 is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.